Latest Menopause Stories

THOUSAND OAKS, Calif., Oct. 14, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has presented data from several Prolia(®) (denosumab) studies, including data from the open-label extension study of the pivotal Phase 3 fracture trial, which showed continued increases in bone mineral density (BMD) and low fracture incidence over six years. These data, and those from several key studies, were presented at the American Society for Bone and Mineral Research (ASBMR) 2012...

Lee Rannals for redOrbit.com - Your Universe Online According to a study published in the journal BMJ, taking hormone replacement therapy (HRT) may reduce the risk of developing heart problems. The researchers found that HRT is not associated with an increased risk of cancer or stroke as several previous studies have claimed, and it also may help reduce the risk of heart attacks. The team followed 1,000 women over 10 years, half of which were on HRTs. Women who took part in the study...

Without any increased risk of cancer, deep vein thrombosis or stroke HRT therapy has been subject to much discussion due to both positive effects (reduced risk of cardiovascular disease) and negative effects (increased risk of breast cancer). A paper published in the BMJ Group's Journal of Family Planning and Reproductive Healthcare back in January cast doubt on the "unreliable" Million Women Study which associated HRT with an increased risk of breast cancer. Conflicting results have...

InShapeMD® in Alpharetta, GA promotes testosterone therapy (BHRT) for both men and women 35 and older with free testosterone testing. Franchise of comprehensive wellness clinics rolls out hormone restoration to InShapeMD® locations nationwide. Alpharetta, GA (PRWEB) October 09, 2012 In an effort to expand its evolving menu of wellness products and services, InShapeMD® in Alpharetta, GA is proudly offering a free testosterone test for men and women via blood (serum) testing...

Joy Behar, of The View, Reviews Hot Girls Pearls on OpenSky.com on October 7th. New York, NY (PRWEB) October 06, 2012 Online shoppers and cool accessory lovers: be sure to tune in to hot social media e-commerce site OpenSky.com (https://opensky.com/joybehar) on October 7th and thereafter. The View co-host and OpenSky.com celebrity curator Joy Behar will be reviewing and recommending HOT GIRLS PEARLS, the first-of-its-kind high-fashion frozen jewelry. HOT GIRLS PEARLS, a collection of...

ORLANDO, Fla., Oct. 5, 2012 /PRNewswire/ -- While hot flashes and night sweats are universally recognized as the most common symptoms associated with menopause, another common symptom can do long-term damage to a woman's physical and emotional well-being. This "silent" symptom known as vaginal discomfort can impact one's quality of life, including couples' relationships. Vaginal discomfort may be caused by vaginal atrophy (VA), a chronic condition due to a decline in estrogen, and...

Kronos Early Estrogen Prevention Study results to help clinicians assess HT risk-benefits PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Kronos Longevity Research Institute (KLRI) today announced that a major finding of the Kronos Early Estrogen Prevention Study (KEEPS) indicates that hormone therapy (HT) improves symptoms of depression and anxiety in recently menopausal women, without adverse effects on cognition. The findings come as a result of a four-year randomized clinical...

PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Estrogen/progesterone treatment started soon after menopause appears safe and relieves many of the symptoms menopausal women face as well as improving mood and markers of cardiovascular risk, according to a multicenter randomized study presented at the North American Menopause Society (NAMS) Annual Meeting in Orlando, Florida. "The KEEPS provides invaluable information for women close to menopause and their clinicians," said S....

NEW YORK, Oct. 3, 2012 /PRNewswire/ -- According to BreastCancer.org, 30% of cancers in women are breast cancers, making it the second most diagnosed cancer among women in America. Although the disease is readily talked about, there are some side effects that remain undisclosed to patients. (Photo: http://photos.prnewswire.com/prnh/20120717/NY41829 ) Since most cases of breast cancer are fueled by the hormone estrogen, when women undergo treatment, it is common for them to take...

MENLO PARK, Calif., Oct. 3, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) announced today that it is presenting two abstracts from its Phase 3 clinical trial, BREEZE 3, at this week's 23(rd) Annual Meeting of the North American Menopause Society (NAMS) in Orlando, FL. The data showed that Serada(®), Depomed's investigational non-hormonal extended-release formulation of gabapentin, may help manage menopausal hot flashes. "Hot flashes are a disruptive problem affecting as many as...